Clinical Trials on Dysferlinopati
Total 5 results
-
University Hospital, Basel, SwitzerlandTerminatedDysferlinopathySwitzerland
-
Sarepta Therapeutics, Inc.Completed
-
Ludwig-Maximilians - University of MunichCompleted
-
Newcastle-upon-Tyne Hospitals NHS TrustJain FoundationActive, not recruitingDysferlinopathy | LGMD2B Now Classified as LGMDR2 | Miyoshi MyopathyKorea, Republic of, Chile, Spain, United States, Denmark, France, Italy, Japan, United Kingdom
-
Human Stem Cell Institute, RussiaGenotargetEnrolling by invitationDysferlinopathy | Miyoshi Myopathy | LGMDR2 | DMATRussian Federation